BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 17176362)

  • 1. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
    Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
    Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in drug prescribing under the Public Health Reform Law--a survey of general practitioners' attitudes in East and West Germany.
    Himmel W; Kron M; Thies-Zajonc S; Kochen MM
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):164-9. PubMed ID: 9112138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic medicines: Greek physicians' perceptions and prescribing practices.
    Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
    J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines].
    Ringuier R; Rouquette A; Dagorne C; Garnier F; Fanello S
    Therapie; 2008; 63(1):11-7. PubMed ID: 18387271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles.
    Niquille A; Ruggli M; Buchmann M; Jordan D; Bugnon O
    Ann Pharmacother; 2010 Apr; 44(4):650-7. PubMed ID: 20215496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.
    de Bakker DH; Coffie DS; Heerdink ER; van Dijk L; Groenewegen PP
    BMC Health Serv Res; 2007 Aug; 7():132. PubMed ID: 17711593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Generic drugs in morocco: survey of physicians].
    Zaoui S; Hakkou F; Filali H
    Therapie; 2011; 66(6):499-506. PubMed ID: 22186075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives.
    Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA
    Fam Pract; 2005 Dec; 22(6):624-30. PubMed ID: 16055474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric homoeopathy in general practice: where, when and why?
    Ekins-Daukes S; Helms PJ; Taylor MW; Simpson CR; McLay JS
    Br J Clin Pharmacol; 2005 Jun; 59(6):743-9. PubMed ID: 15948942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns.
    McGettigan P; McManus J; O'Shea B; Chan R; Feely J
    Ir Med J; 1997; 90(4):146-7. PubMed ID: 9267094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Croatian pharmaceutical sector reform project: rational drug use.
    Harvey K; Kalanj K; Stevanović R
    Croat Med J; 2004 Oct; 45(5):611-9. PubMed ID: 15495290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs.
    Rahmner PB; Gustafsson LL; Larsson J; Rosenqvist U; Tomson G; Holmström I
    Fam Pract; 2009 Apr; 26(2):121-7. PubMed ID: 19103613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
    Pichetti S; Sermet C; Godman B; Campbell SM; Gustafsson LL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):205-18. PubMed ID: 23609765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality circles for pharmacotherapy to modify general practitioners' prescribing behaviour for generic drugs.
    Spiegel W; Mlczoch-Czerny MT; Jens R; Dowrick C
    J Eval Clin Pract; 2012 Aug; 18(4):828-34. PubMed ID: 21615628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
    Federman AD; Halm EA; Siu AL
    Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs.
    Jacoby A; Smith M; Eccles M
    Br J Gen Pract; 2003 Feb; 53(487):120-5. PubMed ID: 12817357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.